Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Invega for Mania in Pediatric Bipolar Disorder
NCT00592358Phase 4Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Nov 2007
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of paliperidone in bipolar disorder (BD), sponsored by Massachusetts General Hospital. Primary endpoint: Young Mania Rating Scale at 8 weeks. Started Nov 2007; status: terminated.
02
Drugs
paliperidone
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00592358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00592358.